Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Histamine and atopic eczema.

J Ring1, P Thomas

  • 1Dermatologische Klinik und Poliklinik, Ludwig-Maximilians-Universität, München.

Acta Dermato-Venereologica. Supplementum
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Properly classifying skin changes. Exanthema--what is what?].

MMW Fortschritte der Medizin·2001
Same author

[Symptomatic therapy of exanthema. Finding the proper externum].

MMW Fortschritte der Medizin·2001
Same author

Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study.

International journal of dermatology·2001
Same author

Calcitriol 3 microg g-1 ointment in combination with ultraviolet B phototherapy for the treatment of plaque psoriasis: results of a comparative study.

The British journal of dermatology·2001
Same author

Desloratadine in the treatment of chronic idiopathic urticaria.

Allergy·2001
Same author

[Toxic epidermal necrolysis (drug-induced Lyell's syndrome). I. Clinical features and differential diagnosis].

Deutsche medizinische Wochenschrift (1946)·2001

Patients with atopic eczema exhibit altered histamine release patterns, with increased spontaneous and stimulated release from leukocytes. This contributes to the characteristic itch and inflammation seen in atopic conditions.

Area of Science:

  • Immunology
  • Dermatology
  • Pharmacology

Background:

  • Atopic eczema is associated with elevated immunoglobulin E (IgE) and dysregulated T-cell responses.
  • Altered release of vasoactive mediators, particularly histamine, is observed in atopic eczema patients.
  • Histamine is a key mediator of pruritus (itch) and other symptoms in atopic diseases.

Purpose of the Study:

  • To investigate the patterns of histamine releasability in patients with atopic eczema.
  • To compare histamine release in atopic eczema patients with healthy individuals.
  • To explore the role of histamine and its receptors in atopic eczema pathogenesis.

Main Methods:

  • In vitro assessment of histamine release from peripheral leukocytes.
  • Stimulation of leukocytes with various agents, including anti-IgE.

Related Experiment Videos

  • Comparison of histamine release between atopic eczema patients and normal controls.

    • Main Results:

    • Increased spontaneous histamine release was observed in atopic eczema patients compared to controls.
    • Leukocytes from atopic eczema patients showed significantly enhanced histamine releasability upon stimulation, especially with anti-IgE.
    • Histamine release reactions appeared to be more rapid in atopics.

    Conclusions:

    • Patients with atopic eczema demonstrate altered histamine release dynamics, characterized by heightened spontaneous and stimulated release.
    • These findings suggest a significant role for histamine dysregulation in the pathophysiology of atopic eczema.
    • Further research into histamine receptor modulation may offer therapeutic strategies for atopic diseases.